Drug Type Small molecule drug |
Synonyms |
Target- |
Action inhibitors |
Mechanism Cell wall inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Essentialis, Inc.Startup |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H25ClN8O8S4 |
InChIKeyNHXPRRKUNVGQBC-AZOXQWDUSA-N |
CAS Registry405268-31-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Positive Bacterial Infections | Phase 1 | United States | - | |
Gram-Positive Bacterial Infections | Phase 1 | - | - | |
Gram-Positive Bacterial Infections | Phase 1 | - | Essentialis, Inc.Startup | - |